Could a simple injection stop pancreatic leaks after surgery?
NCT ID NCT07479784
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a drug called octreotide microspheres can prevent pancreatic fistula, a common and serious leak that can happen after part of the pancreas is removed. About 230 adults scheduled for this surgery will receive either the drug or a placebo. The goal is to see if the drug reduces the number of leaks within 60 days after the operation.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC FISTULA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Scientists hunt for clues to prevent a common complication after pancreatic cancer surgery
- Early warning probe could save lives after pancreatic surgery
- Blood marker may forecast deadly pancreatic surgery complications
- New drain test may spot pancreatic leaks faster
- Radiation before pancreatic surgery may prevent dangerous leaks
- Simple stent may cut pancreatic leak risk after major surgery